Table 1.

Surface markers expressed by MSCs from different sources

Sources	Surface markers	Application prospect
Adipose	CD13, CD90, CD105, STRO-1 [5]	Osteoarthritis, Multiple Sclerosis[6]
Bone marrow	CD90, CD105, CD146, CD271[7]	Stroke, Parkinson’s disease, Alzheimer’s disease[8]
Synovial membrane	CD44, CD73, CD90, CD105[9]	Rheumatoid arthritis, cartilage repair[10]
Perivascular	CD90, CD105, CD248, CD271[11]	Rheumatoid arthritis, bone regeneration[11, 12]
Umbilical cord blood	CD44, CD73, CD90, CD105[13]	Ameliorating psoriasis-like skin lesion[14]
Umbilical cord tissue	CD44, CD73, CD90, CD105[15]	Corneal epithelial repair[15]
Placenta	CD29, CD73, CD90, CD105[16]	Attenuating spinal cord injury in mice [16]
Menstrual blood	CD29, CD73, CD90, CD105[17]	Treating critically ill COVID-19 patients [17]
Dental pulp	CD73, CD90, CD105[18]	Autism spectrum disorder,metatropic dysplasia [19]